Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Respiratory Syncytial Virus in Older Adults: Understanding Risk, Diagnosis, and Evolving Prevention Strategies
  • CME
  • CE

Credits Available
Physicians: maximum of 0.75 AMA PRA Category 1 Credits
Registered Nurses: 0.75 Nursing contact hours
Pharmacists: 0.75 contact hours (0.075 CEUs)
Released: July 21, 2021 Expiration: July 20, 2022
Start Activity
This activity is provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Janssen Therapeutics, Division of Janssen Products, LP
Spencer Durham Headshot
Spencer H. Durham, PharmD, BCPS, BCIDP
person default
Stefan Gravenstein, MD, MPH
person default
Barbara Resnick, PhD, CRNP

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Assess risk for severe RSV development in adults according to age and comorbid conditions
  • Outline vaccine strategies under evaluation for RSV in older adults
  • Apply guideline and data-based RSV prevention strategies in older adults as they become available

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty

Spencer H. Durham, PharmD, BCPS, BCIDP

Assistant Clinical Professor
Pharmacy Practice
Auburn University Harrison School of Pharmacy
Auburn, Alabama
Clinical Pharmacist Specialist, Infectious Diseases
Department of Pharmacy
Central Alabama Veterans Health Care System
Montgomery, Alabama

Spencer H. Durham, PharmD, BCPS, BCIDP, has disclosed that he has received consulting fees from Shionogi and Thera Technologies.
Stefan Gravenstein, MD, MPH

Director
Division of Geriatrics and Palliative Medicine
The Warren Alpert Medical School of Brown University
Providence, Rhode Island

Stefan Gravenstein, MD, MPH, has disclosed that he has received funds for research support from the Genentech, Pfizer, Sanofi, and Seqirus; has received consulting fees from Pfizer and Sanofi; and serves on the data and safety monitoring board for Longeveron.
Barbara Resnick, PhD, CRNP

Professor
School of Nursing
University of Maryland
Nurse Practitioner
Roland Park Pace
Baltimore, Maryland

Barbara Resnick, PhD, CRNP, has no relevant conflicts of interest to report.

Staff

Taryn O'Loughlin Gross, PhD

Editorial Contributor

Taryn O’Loughlin Gross, PhD, has disclosed that she has received support for non-CME activities from Baudax Bio, Curium, and Salix Pharmaceuticals.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Kiran D. Mir-Hudgeons, PhD

Manager, Editorial Operations

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for physicians, pharmacists, advanced practice nurses, and other healthcare providers caring for older adults at risk of severe RSV disease.

Goal

The goal of this activity is to improve learners’ competence in identifying respiratory syncytial virus in older adults and understanding the ongoing prevention clinical research.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-21-134-H01-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 50% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from July 21, 2021, through July 20, 2022:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 50% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

RSV Prevention in Older Adults
  • CME
  • CE

Loading...
Hear expert insights on risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccines for older adults.
Spencer Durham Headshot
Spencer H. Durham, PharmD, BCPS, BCIDP
person default
Stefan Gravenstein, MD, MPH
person default
Barbara Resnick, PhD, CRNP
Physicians: maximum of 0.75 AMA PRA Category 1 Credits
Registered Nurses: 0.75 Nursing contact hours
Pharmacists: 0.75 contact hours (0.075 CEUs)
Released: July 21, 2021 Expiration: July 20, 2022

This program is divided into several short segments that you can access using the Video Chapters menu.

Related Content

From Clinical Care Options (CCO), a patient’s perspective on the road to diagnosis and life with nontuberculous mycobacterial (NTM) lung disease

person default Anonymous Patient Released: September 30, 2021

From Elliott Bosco, PharmD, and Clinical Care Options (CCO), expert commentary on the risks and costs of RSV to older adults in the United States

person default Elliott Bosco, PharmD, PhD Released: August 11, 2021

Video from CCO: overview of respiratory syncytial virus illness and vaccine development in older adults from Drs. Spencer Durham, Stefan Gravenstein, and Barbara Resnick.

Spencer Durham Headshot Spencer H. Durham, PharmD, BCPS, BCIDP person default Stefan Gravenstein, MD, MPH person default Barbara Resnick, PhD, CRNP Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: July 21, 2021 Expired: July 20, 2022

CCO slides: overview of RSV illness and vaccine development in older adults.

Spencer Durham Headshot Spencer H. Durham, PharmD, BCPS, BCIDP person default Stefan Gravenstein, MD, MPH person default Barbara Resnick, PhD, CRNP Released: June 25, 2021

Video Chapters


This activity is provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Janssen Therapeutics, Division of Janssen Products, LP

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue